title: The correction of unilateral aphakia in children treated for orbital rhabdomyosarcoma.
abstract: The survival rate of children with localized orbital rhabdomyosarcoma is now greater than 90% 3 years after diagnosis as a result of advances in radiation and chemotherapy. Ninety percent of these children develop cataracts within 1 to 4 years after the completion of radiotherapy. The correction of aphakia in these children is complicated by the concurrent keratoconjunctivitis and dryness associated with radiotherapy. Three patients with a diagnosis of orbital rhabdomyosarcoma underwent treatment for uniocular cataract. Two of the patients were unable to use extended wear contact lenses. Both underwent epikeratophakia with poor results. One patient who had clinically significant ocular drying prior to cataract extraction underwent successful implantation of an intraocular lens as a primary procedure, with excellent visual results. Clinicians should be aware of the difficulties associated with contact lens wear and epikeratophakia tissue lenses in children who have had high doses of radiation for orbital rhabdomyosarcoma. Such patients are probably best served by primary intraocular lens implantation or by preservation of the posterior capsule at the time of cataract extraction to allow secondary lens implantation if contact lens wear is unsuccessful.
authors.affiliation: LSU Eye Center, Louisiana State University Medical Center School of Medicine, New Orleans 70112.
authors.forename: K S
authors.initials: KS
authors.lastname: Morgan
authors.forename: D E
authors.initials: DE
authors.lastname: Braverman
authors.forename: J D
authors.initials: JD
authors.lastname: Baker
mesh_terms: D001036:Aphakia, Postcataract / Q000628:therapy*; D002386:Cataract / Q000209:etiology* / Q000473:pathology; D002387:Cataract Extraction; D002648:Child; D002675:Child, Preschool; D003261:Contact Lenses; D003316:Corneal Diseases / Q000209:etiology; D015352:Dry Eye Syndromes / Q000209:etiology; D006801:Humans; D007910:Lenses, Intraocular; D008297:Male; D009918:Orbital Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D011878:Radiotherapy / Q000009:adverse effects*; D012208:Rhabdomyosarcoma / Q000188:drug therapy / Q000532:radiotherapy*; D014792:Visual Acuity